NURSING CARE PLAN

ASSESSMENT DIAGNOSIS PLANNING INTERVENTIONS EVALUATION

 Deminished  Ineffective airway  After 8 hours of  Ensured safety  The patient has
breath sound clearance related nursing  Positioned the been discharge.
 Adventitious to excessive Intervention, the baby in
breath mucous secretion patient ‘s comfortable
 (+) cough sound breathing will no position
(crackles) more adventitious  Encourage SO to
sound present verbalized
(crackles) when concerns
auscultatated.  Needs assisted
 Monitored for any
concerns
 Monitored for any
untoward sign and
symptoms
 Maintained head
elevated
 Monitored for
further increase in
RR
 Nebulized the
patient
 Administered
nasoclear nasal
spray at 12 nn
Given by the nurse
 Demonstrated to
SO in performing
specific airway
clearance
techniques
 Watched out for
sign of Respiratory
distress.
 DRUG STUDY

GENERIC BRAND CLASSIFICA ACTION DOSAGE INDICATION ADVERSE REACTION NURSING

NAME NAME TION RESPONSIBILITIES
Cefuroxi Ceftin semisynthe prescribed to 3x a day Treatment for Common side effects of > Assess lung sounds,
me Zinacef tic treat (8A anti bacteria Ceftin include diarrhea, respiratory pattern, pulse
cephalospo infections 1P dizziness, headache, and blood pressure
rin antibioti with 8P) drowsiness, before administration
susceptible itching/swelling, rash, and during peak of
bacteria nausea, vomiting, medication
abdominal pain, stomach > Monitor pulmonary
upset, gas, headache, function tests before
itching or rash, hives, initiating therapy and
cough, stuffy nose, stiff or periodically throughout
tight muscles, muscle course to determine
pain, joint pain or effectiveness of
swelling, restlessness, medication
irritability, hyperactivity, > Observe patient for
vaginal itching or drug tolerance and
discharge, unusual or rebound bronchospasm.
unpleasant taste in the If condition occurs,
mouth white patches or withhold medication and
sores in the mouth, and notify physician
diaper rash (in infants immediately.
taking liquid cefuroxime).
CELESTA Betameth Respiratory control the Taking 1.0 ml treatment of Adverse reactions to this > Administer only the
MINE asone/De dermatolog exudative 3 times a day difficult cases of component, which have drug that you prepare
xchlorphe ic and and (8A respiratory, been the same as those > If patient refuses
namine ocular inflammator 1P dermatologic and reported with other medication, ask a relative
Maleate allergies y aspects of 8P) ocular allergies, corticosteroids, are to assist in administering
ocular as well as ocular related to dose and the medications.
diseases, inflammatory duration of therapy. The > Evaluate client's
thus helping disorders, where small amount of condition and medication
to preserve adjunctive corticosteroid in the compatibility
the systemic combination makes the Check for skin integrity
functional corticosteroid incidence of side effects
integrity of therapy is less likely.
the eye while indicated. Adverse reactions
allowing reported for
treatment of corticosteroids
the specific include: Fluid and
infection or Electrolyte
other cause Disturbances Sodium
with retention, potassium loss,
appropriate hypokalemic alkalosis;
therapy. fluid retention; congestive
heart failure in susceptible
patients; hypertension.
 Muskoskeletal: M
uscle weakness
 Dermatologic: Imp
aired would
healing, skin
atrophy, thin
fragile skin;
petechiae and
ecchymoses;
facial erythema;
increased
sweating
 Neurologic: Convu
lsions
 Metabolic: Negati
ve nitrogen
balance due to
protein
catabolism.
The most common
 effects include
sedation, sleepiness,
dizziness, disturbed
coordination,
epigastric distress,
rash, dry mouth and
thickening of
bronchial secretions.

Allerzet Cevecetiri Allergic Mean oral Taking Twice TREATMENTreat Common (>1%): Adults > Administer only the
zine rhinitis total body a day ment for allergy and Children >12 years: drug that you prepare
Dihydroch clearance is (8A reaction Somnolence, headache, > If patient refuses
loride approximatel 8P) fatigue, dry mouth, medication, ask a relative
y 0.63 nasopharyngitis and to assist in administering
mL/kg/min. pharyngitis. the medications. >
Clearance of Children 6-11 years: Evaluate client's
levocetirizine Pyrexia, somnolence, condition and medication
may not be cough, epistaxis, and compatibility
significantly rhinitis. > Administer medicine at
decreased in Uncommon (0.1-1%) to the time specified or as
patients with Very Rare (<0.01%): close to that time as
solely General: Asthenia, possible—if there is a
hepatic malaise, edema, delay, document it.
impairment hypersensitivity and > Evaluate client's
since anaphylactic shock. condition and medication
levocetirizine Neurologic: Agitation, compatibility
is mainly paresthesia, aggression,
excreted confusion, depression,
unchanged hallucination, insomnia,
by the convulsions, movement
kidneys. disorders, tic, dysgeusia,
Dosage syncope, tremor, dystonia
adjustment and dyskinesia.
is necessary Dermatologic: Pruritus,
for mild to rash, urticaria,
severe renal angioneuroticedema and
impairment fixed drug eruption.
Gastrointestinal:
Abdominal pain and
diarrhea.
Hepatobiliary: Increased
transaminases, alkaline
phosphatase, γ-
glutamyltranspeptidase
(GGT) and bilirubin.
Ophthalmic:
Accomodation disorder,
blurred vision and
oculogyration.
Genitourinary: Dysuria
and enuresis.
Others: Tachycardia,
thrombocytopenia and
increased weight.
Erythrom Oral, Macrolide  Erythromycin Taking trice a Acute infection Rash, urticaria; nausea, >Administer around the
ycin ophthalm antibiotic inhibits day (8A caused by vomiting, GI discomfort, clock to maximize effect;
ic protein 1P sensitive strains ototoxicity; central adjust schedule to
ointment synthesis by 8P) of Streptococcus neurotoxicity; minimize sleep disruption
irreversibly pneumonia, agranulocytosis;arrhythmi
binding to Mycoplasma as;pancreatitis.
the 50S pneumonia , Potentially Fatal:
ribosomal Listeria Hepatotoxicity, cholestatic
subunit thus monocytogenes, jaundice; raised serum
blocking the Legionella transaminase;
transpeptida pneumophila eosinophilia
tion or URIs, lower 
translocation respiratory tract
reactions of infections, skin
susceptible and soft tissue
organisms infections caused
resulting in by group A beta-
stunted cell hemolytic
growth. streptococci
when oral
treatment is
preferred to
injectable
benzathine
penicillin
PID caused by N.
gonorrhoeae in
patients allergic
to penicillin
In conjunction
with
Sulphonamides in
URIs caused by
Haemophilus
influenza
As an adjunct to
antitoxin in
infections caused
by
Corynebacterium
diphtheriae and
Corynebacterium
minutissimum
Prophylaxis
against alpha-
hemolytic
streptococcal
endocarditis
before dental or
other procedures
in patients
allergic who have
valvular heart
disease
Oral
erythromycin :
Treatment of
intestinal
amebiasis caused
by
Entamoebahistoly
tica ; infections in
the newborn and
in pregnancy that
are caused by
Chlamydia
trachomatis and
in adult
chlamydial
infections when
tetracycline
cannot be used;
Primary syphilis
(treponemapallid
um) in penicillin –
allergic patient;
eliminating
Bordetella
pertussis
organism from
the nasopharynx
of infected
individuals and as
prophylaxis in
exposed and
susceptible
individuals.
Unlabeled uses:
Erythromycin
base is used with
neomycin before
colorectal surgery
to reduce wound
infection;
treatment of
severe diarrrhea
associated with
Campylobacter
enteritis or
enterocolitis:
treatment of
genital, inguinal,
or
anorectallymphog
ranulomayenereu
m infection:
treatment of
Haemophilusducr
evi (chancroid)